Skip to main content

Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project

Abstract

Background

The link between depression and paranoia has long been discussed in psychiatric literature. Because the causality of this association is difficult to study in patients with full-blown psychosis, we aimed to investigate how clinical depression relates to the presence and occurrence of paranoid symptoms in clinical high-risk (CHR) patients.

Methods

In all, 245 young help-seeking CHR patients were assessed for suspiciousness and paranoid symptoms with the structured interview for prodromal syndromes at baseline, 9- and 18-month follow-up. At baseline, clinical diagnoses were assessed by the Structured Clinical Interview for DSM-IV, childhood adversities by the Trauma and Distress Scale, trait-like suspiciousness by the Schizotypal Personality Questionnaire, and anxiety and depressiveness by the Positive and Negative Syndrome Scale.

Results

At baseline, 54.3 % of CHR patients reported at least moderate paranoid symptoms. At 9- and 18-month follow-ups, the corresponding figures were 28.3 and 24.4 %. Depressive, obsessive–compulsive and somatoform disorders, emotional and sexual abuse, and anxiety and suspiciousness associated with paranoid symptoms. In multivariate modelling, depressive and obsessive–compulsive disorders, sexual abuse, and anxiety predicted persistence of paranoid symptoms.

Conclusion

Depressive disorder was one of the major clinical factors predicting persistence of paranoid symptoms in CHR patients. In addition, obsessive–compulsive disorder, childhood sexual abuse, and anxiety associated with paranoia. Effective pharmacological and psychotherapeutic treatment of these disorders and anxiety may reduce paranoid symptoms in CHR patients.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Freeman D (2007) Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev 27:425–457

    Article  PubMed  Google Scholar 

  2. 2.

    Kraepelin E (1899) Psychiatrie. Sechste, vollständig umgearbaitete Auflage. Leibzig, Johan Ambrosius Barth, Ein Lehrbuch für Studierende und Aerzte, p 1899

    Google Scholar 

  3. 3.

    Souery D, Zaninotto L, Calati R, Linotte S, Mendlewicz J, Sentissi O, Serretti A (2012) Depression across mood disorders: review and analysis in a clinical sample. Compr Psychiatry 53:24–38

    Article  PubMed  Google Scholar 

  4. 4.

    Manschreck TC, Khan NL (2006) Recent advances in the treatment of delusional disorder. Can J Psychiatry 51:114–119

    PubMed  Google Scholar 

  5. 5.

    de Portugal E, González N, Haro JM, Autonell J, Cervilla JA (2008) A descriptive case-register study of delusional disorder. Eur Psychiatry 23:125–133

    Article  PubMed  Google Scholar 

  6. 6.

    Bentall RP, Corcoran R, Howard R, Blackwood N, Kinderman P (2001) Persecutory delusions: a review and theoretical integration. Clin Psychol Rev 21:1143–1192

    Article  CAS  PubMed  Google Scholar 

  7. 7.

    Bebbington P, Jonas S, Kuipers E, King M, Cooper C, Brugha T, Meltzer H, McManus S, Jenkins R (2011) Childhood sexual abuse and psychosis: data from a cross-sectional national psychiatric survey in England. Br J Psychiatry 199:29–37

    Article  PubMed  Google Scholar 

  8. 8.

    Häfner H, Maurer K (1991) Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to the first admission. In: Marneros A, Andreasen NC, Tsuan MT (eds) Negative versus positive schizophrenia. Springer, Berlin, pp 134–159

    Chapter  Google Scholar 

  9. 9.

    Svirskis T, Korkeila J, Heinimaa M, Huttunen J, Ilonen T, Ristkari T, McGlashan T, Salokangas RK (2005) Axis-I disorders and vulnerability to psychosis. Schizophr Res 75:439–446

    Article  PubMed  Google Scholar 

  10. 10.

    Salokangas RKR, Ruhrmann S, Graf von Reventlow H, Heinimaa M, Svirskis T, From T, Luutonen S, Juckel G, Linszen D, Dingemans P, Birchwood M, Patterson P, Schultze-Lutter F, Klosterkötter J, The EPOS Group (2012) Axis I diagnoses and transition to psychosis in clinical high-risk patients. EPOS project: prospective follow-up of 245 clinical high-risk out-patients in four countries. Schizophr Res 138:192–197

    Article  PubMed  Google Scholar 

  11. 11.

    Zhang T, Li H, Woodberry KA, Seidman LJ, Zheng L, Li H, Zhao S, Tang Y, Guo Q, Lu X, Zhuo K, Qian Z, Chow A, Li C, Jiang K, Xiao Z, Wang J (2014) Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res 152:391–399

    PubMed Central  Article  PubMed  Google Scholar 

  12. 12.

    Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2014) Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull 40:120–131

    PubMed Central  Article  PubMed  Google Scholar 

  13. 13.

    Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Linszen D, Birchwood M, Juckel G, Morrison A, Vázquèz-Barquero Hambrecht M, von Reventlow H, The EPOS Group (2005) The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 4:161–167

    PubMed Central  PubMed  Google Scholar 

  14. 14.

    Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, Graf von Reventlow H, Klosterkötter J (2010) Prediction of psychosis in adolescents and young adults at high risk: results from the Prospective European Prediction of Psychosis Study. Arch Gen Psychiatry 67:241–251

    Article  PubMed  Google Scholar 

  15. 15.

    Schultze-Lutter F, Klosterkötter J (2002) Bonn scale for assessment of basic symptoms—prediction list, BSABS-P. University of Cologne, Cologne

    Google Scholar 

  16. 16.

    McGlashan TH, Miller TJ, Woods SW et al (2001) Structured interview for prodromal syndromes (Version 3.0, unpublished manuscript). New Haven, Connecticut, PRIME Research Clinic, Yale School of Medicine

  17. 17.

    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC

    Google Scholar 

  18. 18.

    Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276

    Article  CAS  PubMed  Google Scholar 

  19. 19.

    Patterson P. Skeate A. Schultze-Lutter F, von Reventlow H (2002) Trauma and Distress Scale, TADS—EPOS version 1.2. 2002

  20. 20.

    Raine A (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 17:555–564

    Article  CAS  PubMed  Google Scholar 

  21. 21.

    Cutting J (1997) Principles of psychopathology: two worlds-two minds-two hemispheres. Oxford University Press, Oxford

    Google Scholar 

  22. 22.

    Schultze-Lutter F, Renner F, Paruch J, Julkowski D, Klosterkötter J, Ruhrmann S (2014) Self-reported psychotic-like experiences are a poor estimate of clinician-rated attenuated and frank delusions and hallucinations. Psychopathology 47:194–201

    Article  PubMed  Google Scholar 

  23. 23.

    Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG (2014) Prevalence and clinical significance of DSM-5-attenuated psychosis syndrome in adolescents and young adults in the general population: the Bern Epidemiological At-Risk (BEAR) Study. Schizophr Bull 40:1499–1508

    PubMed Central  Article  PubMed  Google Scholar 

  24. 24.

    Pine DS, Cohen JA (2002) Trauma in children and adolescents: risk and treatment of psychiatric sequelae. Biol Psychiatry 51:519–531

    Article  PubMed  Google Scholar 

  25. 25.

    Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP (2012) Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull 38:661–671

    PubMed Central  Article  PubMed  Google Scholar 

  26. 26.

    Bentall RP, Wickham S, Shevlin M, Varese F (2012) Do specific early life adversities lead to specific symptoms of psychosis? A study from the 2007 the Adult Psychiatric Morbidity Survey. Schizophr Bull 38:734–740

    PubMed Central  Article  PubMed  Google Scholar 

  27. 27.

    Sitko K, Bentall RP, Shevlin M, O’Sullivan N, Sellwood W (2014) Associations between specific psychotic symptoms and specific childhood adversities are mediated by attachment styles: an analysis of the National Comorbidity Survey. Psychiatry Res 217:202–209

    Article  PubMed  Google Scholar 

  28. 28.

    Marwaha S, Bebbington P (2015) Mood as a mediator of the link between child sexual abuse and psychosis. Soc Psychiatry Psychiatr Epidemiol 50:661–663

    PubMed Central  Article  CAS  PubMed  Google Scholar 

  29. 29.

    Kendler KS, Masterson CC, Davis KL (1985) Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness. Br J Psychiatry 147:524–531

    Article  CAS  PubMed  Google Scholar 

  30. 30.

    Manschreck TC (1989) Delusional (paranoid) disorders. In: Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry/V, vol 1, 5th edn. Williams & Wilkins, Baltimore, pp 816–829

    Google Scholar 

  31. 31.

    Fusar-Poli P, Meyer-Lindenberg A (2013) Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F]/[11C] DOPA PET studies. Schizophr Bull 39:33–42

    PubMed Central  Article  PubMed  Google Scholar 

  32. 32.

    Hietala J, Syvälahti E, Vilkman H, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M, Solin O, Kuoppamäki M, Eronen E, Ruotsalainen U, Salokangas RK (1999) Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res 35:41–50

    Article  CAS  PubMed  Google Scholar 

  33. 33.

    Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009) Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 66:13–20

    Article  PubMed  Google Scholar 

  34. 34.

    Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, McGuire P (2011) Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 168:1311–1317

    PubMed Central  Article  PubMed  Google Scholar 

  35. 35.

    Laruelle M (2003) Dopamine transmission in schizophrenic brain. In: Hirsch SR, Weinberger D (eds) Schizophrenia, 2nd edn. Blackwell Science Ltd, Bath, pp 365–387

    Chapter  Google Scholar 

  36. 36.

    Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P, PRIAMO Study Group (2012) Psychosis associated to Parkinson’s disease in the early stages: relevance of cognitive decline and depression. J Neurol Neurosurg Psychiatry 83:76–82

    Article  PubMed  Google Scholar 

  37. 37.

    Freeman D, Dunn G, Murray RM, Evans N, Lister R, Antley A, Slater M, Godlewska B, Cornish R, Williams J, Di Simplicio M, Igoumenou A, Brenneisen R, Tunbridge EM, Harrison PJ, Harmer CJ, Cowen P, Morrison PD (2015) How cannabis causes paranoia: using the intravenous administration of ∆9-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia. Schizophr Bull 41:391–399

    PubMed Central  Article  PubMed  Google Scholar 

  38. 38.

    Wood JG, Joyce PR, Miller AL, Mulder RT, Kennedy MA (2002) A polymorphism in the dopamine beta-hydroxylase gene is associated with “paranoid ideation” in patients with major depression. Biol Psychiatry 51:365–369

    Article  CAS  PubMed  Google Scholar 

  39. 39.

    Howes OD, Murray RM (2014) Schizophrenia: an integrated sociodevelopmental-cognitive model. Lancet 383:1677–1687

    PubMed Central  Article  PubMed  Google Scholar 

  40. 40.

    Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160:13–23

    Article  PubMed  Google Scholar 

  41. 41.

    Schmidt SJ, Grunert VM, Schimmelmann BG, Schultze-Lutter F, Michel C (2014) Differences in coping, self-efficacy, and external control beliefs between patients at-risk for psychosis and patients with first-episode psychosis. Psychiatry Res 219:95–102

    Article  PubMed  Google Scholar 

  42. 42.

    Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85–102

    Article  CAS  PubMed  Google Scholar 

  43. 43.

    Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A (2012) The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res 36:427–440

    Article  Google Scholar 

  44. 44.

    Schmidt SJ, Schultze-Lutter F, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Klosterkötter J, Ruhrmann S (2015) EPA guidance on the early intervention in clinical high risk states of psychoses. Eur Psychiatry 30:388–404

    Article  CAS  PubMed  Google Scholar 

  45. 45.

    Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR (2012) Interpersonal sensitivity in the at-risk mental state for psychosis. Psychol Med 42:1835–1845

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The International Advisory Board ‘European Prediction of Psychosis’ (EPOS) group comprises Patrick D. McGorry, Australia; Thomas H. McGlashan, USA; Martin Knapp, UK. The authors thank the following scientists for their work for EPOS: Reinaud van der Fliert, Rianne Klaassen (Department of Psychiatry, AMC, University of Amsterdam, The Netherlands); Heinz Picker, Meike Neumann, Anke Brockhaus-Dumke, Ralf Pukrop (Department of Psychiatry and Psychotherapy/FETZ, University of Cologne, Cologne, Germany); Jukka Huttunen, Terja Ristkari (Department of Psychiatry, University of Turku, Finland); Tanja Svirskis (Department of Psychiatry, University of Helsinki, Helsinki, Finland); Amanda Skeate (ED: IT, Early Intervention Service, Birmingham, UK); Yehonala Gudlowski (Charité, Berlin, Germany); Seza Ozgürdal, Henning Witthaus (Charité, Berlin, and Ruhr-University, Bochum, Germany); Shôn Lewis, Antony Morrisson (School of Psychological Sciences, University of Manchester, Manchester, UK).

Author information

Affiliations

Authors

Consortia

Corresponding author

Correspondence to Raimo K. R. Salokangas.

Ethics declarations

Funding

This study was funded by Grant QLG4-CT-2001-01081 from the 5th Framework Program Quality of Life and Management of Living Resources of the European Commission. Additional local funding was provided by the Social Insurance Institution of Finland, the Medical Faculty of Cologne (Köln Fortune Program), the Research Council of The Netherlands (ZorgOnderzoek Nederland/NWO-Medische Wetenschappen, project # 2630.0001), the National Institute for Health Research (NIHR) through the Collaborations for Leadership in Applied Health Research and Care for Birmingham and the Black Country (CLAHRC-BBC)’ and Oy H. Lundbeck AB, Finland.

Conflict of interest

None.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Salokangas, R.K.R., Schultze-Lutter, F., Hietala, J. et al. Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project. Soc Psychiatry Psychiatr Epidemiol 51, 247–257 (2016). https://doi.org/10.1007/s00127-015-1160-9

Download citation

Keywords

  • Depression
  • Anxiety
  • Paranoia
  • Persistence
  • Clinical high risk